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with comparable infarction alone, with an initial rise in prohypertrophic and antiapoptotic signals (specifically, the Aktphosphatidylinositol 3'-kinase and gp130-janus kinase (JAK)/ signal transducer and activator of transcription 3 (STAT3) pathways), followed by their exhaustion. In the same model, early repair (after 1 month) 18 of the MR-equivalent LV-to-LA shunt prevents downregulation of these compensatory pathways and induces LV reverse remodeling manifested by normalization of both functional and anatomic parameters, also consistent with other ischemic MR models and therapeutic approaches. 10, 19, 20 However, it is not known whether the molecular alterations and LV remodeling can be reversed by a late intervention done when the prohypertrophic and antiapoptotic signals are already downregulated.
Based on this observed biphasic molecular response in ischemic MR, we specifically hypothesized that late MR repair would not result in LV reverse remodeling. This was tested using our previously described animal model of ischemic MR combining an apical MI and an LV-to-LA shunt, with shunt ligation at 3 months after MI to simulate MR repair.
Methods

Ischemic MR Model
A previously described ischemic MR model was created in 12 adult Dorsett hybrid sheep (weight >45 kg). 17, 18 This model, combining an apical infarction by distal left anterior descending coronary artery ligation (not causing MR by itself) and an LV to LA shunt (8-cm long, 8-mm diameter-reinforced Teflon graft with a cross-sectional area of 50 mm 2 implanted into the LV base and left atrial appendage as shown in Figure 1 ), has been shown to produce standardized and consistent MI size and moderate volume overload. Ninety days after the initial surgery, a second thoracotomy was repeated, and sheep were randomized to shunt closure (late repair group) or sham surgery (no repair group). The animals were observed for an average of 6 more weeks and euthanized on day 135 (Figure 2 ). The 90 days late repair timing was chosen on the basis of previous studies in the same model showing exhaustion of prohypertrophic compensatory pathways at this time. 17, 18 Animal studies conformed to National Institutes of Health guidelines (National Research Council, Washington, DC, 1996) and were approved by the Institutional Review Board.
Echocardiography Analysis
Standard 2-dimensional and full-volume 3-dimensional data sets were obtained epicardially at each time point (baseline, 90 days, and 135 days) using high-frequency (S5, X3) probes and a Philips iE33 scanner (Andover, MA). Shunt patency or closure was confirmed by color flow Doppler. Three-dimensional analysis was performed blinded to group and time point using the custom software Omni4D (MD Handschumacher) as previously described. 18 LV end-diastolic and end-systolic volumes (ESV) were measured and LV ejection fraction computed. Regurgitant volume was calculated as total 3-dimensional stroke volume (end-diastolic volume-ESV) minus forward aortic stroke volume calculated by pulsed wave Doppler and the continuity equation. Regurgitant volume and fraction, therefore, included the regurgitant flow through the LV-to-LA shunt, but also accounted for any additional functional MR that could have occurred secondary to LV dilatation in the context of combined MI and volume overload.
LV Pressure-Volume Analysis
At baseline and day 135, a high-fidelity conductance catheter (Scisense, Ontario, Canada) was inserted transapically to record LV maximal dP/dt and pressure-volume relationship under different preload conditions by simultaneously partially occluding the inferior vena cava, with subsequent computation of preload-recruitable stroke work (PLRSW), 18 ,21 a preload independent measure of LV systolic contraction.
Tissue Samples and Molecular Analysis
Myocardial needle biopsy was performed at baseline before model creation, and both peri-infarct and remote myocardium were biopsied at days 90 and 135. We measured levels of pAKT (protein kinase B), central in the hypertrophic process, and pSTAT3, a critical node in the hypertrophic stimulus by cytokines. Both these, at their respective levels (cytosol and membrane), are important crossroads in prohypertrophic signaling. 18 Western blot analysis was performed on cell lysates from biopsies at baseline, day 90, and day 135. pSTAT3 and anti-phosphoAkt (Santa Cruz Biotechnology, Santa Cruz, CA) were detected with peroxidase-conjugated anti-mouse IgG and chemiluminescence, with α-actin as the housekeeping control. Integrated blot pixel density was assessed using standard software (ImageJ; National Institutes of Health, Bethesda, MD).
Statistics
Continuous variables are expressed as mean±SD. Differences within and between groups at different time points were assessed with repeated-measures ANOVA. Rank-based ANOVA was performed when normality was excluded by the Shapiro-Wilk test. P<0.05 was considered significant. Based on previous data with the same model, it was calculated that a sample size of 6 per group would provide ≥80% power (α level, 0.05) to detect an effect comparable with early MR repair between groups (25 mL·mm Hg in preload-recruitable stroke work and 40 mL in ESV). Statistical analysis was performed with Stata/IC 11.2 (StataCorp LP, TX).The authors had full access to and take full responsibility for the integrity of data.
Results
LV Volumes and Function
A total of 16 sheep underwent the initial procedure of MI+MR. Four sheep died suddenly within the first 48 hours, presumably from malignant arrhythmia. A total of 12 sheep completed the protocol successfully, without death occurring after randomization of MR repair versus sham procedure. As expected, the Figure 3 ). LV hemodynamics showed the same pattern: preload-recruitable stroke work was significantly and equally reduced at euthanasia in both groups ( Figure 4 ; 41±7 versus 39±13 mL·mm Hg, P=0.70). Maximal dP/dt also declined over time comparably in both groups at euthanasia (803±210 versus 732±194 mm Hg/s, P=0.56).
Molecular Analysis
Western blot-integrated density of prohypertrophic markers pAKT and pSTAT3 at 3 time points is displayed in Figure 5 . As expected, both groups had similarly decreased signals for these markers at 90 days. However, late repair did not result in recovery, and both groups were equally depressed at day 135 (P=0.16).
Discussion
In this study, we show that late correction of a moderate volume overload 3 months post-MI does not reverse or prevent further LV remodeling and dysfunction, with consistent outcomes at the functional and molecular levels. These results contrast with a previously published study, 18 in which early (1 month) repair was associated with complete normalization of ventricular volume, hemodynamic alteration, and molecular alteration.
Despite its clear association with poorer prognosis, 4 treatment of ischemic MR remains highly controversial. Both clinical 5, 22, 23 and experimental 6,10,18 studies yield conflicting results. Part of this controversy is attributable to the complex nature of LV remodeling associated with ischemic MR: the MI initially causes the MR, but both MI and MR can contribute to cellular and functional changes in the noninfarcted LV. 17 The relative contribution of MI and MR has been difficult, if not impossible, to separate in clinical studies. Other confounders relate to MR surgical correction, often performed with simultaneous coronary revascularization and with the frustrating problem of recurrent MR, treating the volume overload often only partially or temporarily. [7] [8] [9] This animal model of apical MI with LV-to-LA shunt can help resolve these difficulties. By isolating the effect of moderate volume overload on comparable MI size and location, it previously demonstrated the additional contribution of moderate MR to LV remodeling. The second advantage is the adequate and persistent correction of volume overload by shunt ligation, simulating a successful and minimally invasive MR repair. In this controlled environment, the current experimental study provides another possible explanation for discrepancies between clinical studies by suggesting that a successful surgical correction can produce variable results if not performed in a timely manner.
This variable response to correction at different time points needs to be related to the previously observed biphasic molecular response in the myocardium after MI and MR. Cardiac remodeling in ischemic MR is dynamic: increased apoptotic tone (caspase-3) has been shown in remote myocardium, partially counterbalanced by transiently increased 
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prohypertrophic and antiapoptotic pathways: the gp130-STAT3 pathway is related to cytokine-mediated hypertrophy, and protein kinase B (Akt) is a serine/threonine-specific protein kinase promoting growth factor-mediated cell survival and hypertrophy. Signaling of both pathways is increased after MI, but the presence of moderate volume overload is associated with subsequent downregulation paralleling the transition to heart failure. 17, 24 Early MR repair when performed while gp130 and Akt are still overexpressed can interrupt the vicious remodeling cycle and reverse heart failure. The lack of success of the same procedure after downregulation of these compensatory pathways indicates a point of no return for LV remodeling in ischemic MR and suggests a limited time window to correct the MR, with less or no beneficial effect if the intervention is not performed within this interval. The persistent negative remodeling observed after late MR repair suggests that these profound molecular alterations not only prevent reversal of heart failure but could also contribute to further LV remodeling even after the correction of the initial volume overload.
Clinical Correlation and Future Studies
Clinical criteria to correct MR surgically are generally based on MR severity, LV dimensions, and function. Although clinically important and useful, these parameters might not be sufficient to capture the whole spectrum of LV remodeling or completely predict outcome after surgery for ischemic MR. Although the current study suggests that earlier repair is better to prevent LV remodeling, determining the best timing for intervention in a clinical setting will remain a challenge because each patient presents variable MI size, MR severity, and myocardial substrate and, therefore, an individual time window. Although preoperative echocardiography assessment can help predict procedural success in terms of MR correction 25 and that parameters, such as LV dimension, can be useful to assess the remodeling, it is unclear at this point how well imaging (other than LV dimensions and function) and biomarkers can improve the prediction of ventricular response after successful MR repair. Another question will be whether and how current and future medical therapies can prolong the time during which beneficial repair can be performed. Welldesigned clinical and experimental studies are needed to answer these relevant questions properly.
Limitations
While helping to understand the effects and potential implications of volume overload correction on LV remodeling, direct extrapolation to patients with ischemic MR cannot be made at this point. This animal model was designed to separate the results of MI and volume overload on LV remodeling and to study the effects of successful MR repair, but does not fully represent the clinical scenario. However, these results highlight the dynamic nature of LV remodeling in ischemic MR and the importance of timing when considering surgical intervention. Our power was sufficient to rule out changes of the magnitude observed by early repair, but the relative small sample size could not rule out a smaller beneficial effect of late repair compared with no treatment. Although we previously used this model to show the beneficial effects of early repair, 18 LV volume was measured differently in the current study (real-time 3-dimensional echocardiography versus 
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September 10, 2013 sequential rotational acquisitions). This may possibly account for the larger variability in volume measurement observed in the previous study. Thus, although the differences in evolution after repair in the 2 studies are striking, direct comparison of LV volume between the studies cannot be made.
Conclusions
In this ischemic MR animal model, late MR repair was not beneficial to prevent additional LV remodeling, in contrast to earlier repair. This suggests a point of no return after which no or limited beneficial effect of MR repair can be achieved, despite adequate correction of volume overload. The timing of valve repair in ischemic MR needs to be assessed in future clinical studies because this could, in part, resolve controversies and discrepant findings in this area. 
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